Hikma Pharmaceuticals (HIK)

 

HIK Share PerformanceMore

52 week high1,717.0 02/06/17
52 week low814.0 01/03/18
52 week change -318.5 (-19.13%)
4 week volume13,464,293 01/05/18
price1,346.5
price date1527270346
close1,339.5

Latest NewsMore

Director Deals - Hikma Pharmaceuticals PLC (HIK)

John Castellani, Non Executive Director, bought 1,000 shares in the company on the 22nd May 2018 at a price of 1376.95p. T...

Director/PDMR Shareholding

RNS Number: 0225P Hikma Pharmaceuticals Plc 23 May 2018 Notification and public disclosure of transactions by persons discharging managerial responsibilities 1 Details of the person discharging managerial responsibilities / person closely associated a) Name John Castellani 2 Reason for the notification a) Position/status Non-Executive Director b) Initial notificatio...

AGM Results

Notification of the result of any voting at an AGM

Broker Forecast - Numis issues a broker note on Hikma Pharmaceuticals PLC

Numis today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to add (from buy) and raised...

UK stocks open 0.2% lower as AstraZeneca disappoints

UK stocks opened weaker on Friday as drugs giant AstraZeneca posted disappointing earnings results and the pound streng...

Hikma Pharmaceuticals reiterates full-year guidance

Hikma Pharmaceuticals reiterated its full-year guidance on Friday after reporting that its injectables, generics and brande...

Trading Statement

Statement regarding a company’s trading performance (e.g. profit warning)

Director/PDMR Shareholding

RNS Number: 4600O Hikma Pharmaceuticals Plc 17 May 2018 Hikma Pharmaceuticals PLC - EIP Awards LONDON, 17 May 2018: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) (LEI: 549300BNS685UXH4JI75) announces that the Remuneration Committee has made the following conditional awards and nil cost option under the Hikma Pharmaceutica...

Fundamental DataMore

P/E ratio20.248
EPS66.5
Dividend yield2.451 %

Latest discussion posts More

  • Director dealing

    bought 1000 !
    23-May-2018
    paul1945
  • Re: Trading Update

    NUMIS TARGET 1560 ANOTHER #10 I WILL BE IN PROFIT
    18-May-2018
    paul1945
  • Trading Update

    Judging by the way the share price was up & down today brokers weren't sure if the update was good or bad. My view was it was on balance good, showing steady progress; and I ...
    18-May-2018
    Hardboy

Users' HoldingsMore

Users who hold Hikma Pharmaceuticals also hold..

Codes & Symbols

ISINGB00B0LCW083
SymbolsHIK, LSE:HIK, HIK.L, HIK:LN, LON:HIK, XLON:HIK